HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julie Brewer Selected Research

SP 1049C

10/2011A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julie Brewer Research Topics

Disease

1Anus Neoplasms (Anal Cancer)
12/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2018
1Neoplasms (Cancer)
10/2011
1Neutropenia
10/2011
1Disease Progression
10/2011
1Adenocarcinoma
10/2011

Drug/Important Bio-Agent (IBA)

1SP 1049CIBA
10/2011
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2011
1Poloxamer (Poloxamer 407)IBA
10/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2011

Therapy/Procedure

1Chemoradiotherapy
12/2018
1Drug Therapy (Chemotherapy)
10/2011
1Intravenous Infusions
10/2011